Clinical Trial: A Randomized, Open-label, Active-Drug-Controlled, Single Dose Escalation and Multiple Administration Study of IPG for Injection in Healthy Menopausal Female Subjects (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Open-label, Active-Drug-Controlled, Single Dose Escalation and Multiple Administration Study of IPG for Injection in Healthy Menopausal Female Subjects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135793

Registration Time: 2026/11/02

Type: Interventional study

Primary Sponsor: Henan Infectious Disease Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=247316

Published by HT Digital Content Services with permission from Health Daily Digest....